These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
826 related articles for article (PubMed ID: 17419714)
1. Immune activation suppresses initiation of lytic Epstein-Barr virus infection. Ladell K; Dorner M; Zauner L; Berger C; Zucol F; Bernasconi M; Niggli FK; Speck RF; Nadal D Cell Microbiol; 2007 Aug; 9(8):2055-69. PubMed ID: 17419714 [TBL] [Abstract][Full Text] [Related]
2. Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases. Niller HH; Wolf H; Minarovits J Autoimmunity; 2008 May; 41(4):298-328. PubMed ID: 18432410 [TBL] [Abstract][Full Text] [Related]
3. A molecular link between malaria and Epstein-Barr virus reactivation. Chêne A; Donati D; Guerreiro-Cacais AO; Levitsky V; Chen Q; Falk KI; Orem J; Kironde F; Wahlgren M; Bejarano MT PLoS Pathog; 2007 Jun; 3(6):e80. PubMed ID: 17559303 [TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus BZLF1 gene, a switch from latency to lytic infection, is expressed as an immediate-early gene after primary infection of B lymphocytes. Wen W; Iwakiri D; Yamamoto K; Maruo S; Kanda T; Takada K J Virol; 2007 Jan; 81(2):1037-42. PubMed ID: 17079287 [TBL] [Abstract][Full Text] [Related]
5. EBV lytic-phase protein BGLF5 contributes to TLR9 downregulation during productive infection. van Gent M; Griffin BD; Berkhoff EG; van Leeuwen D; Boer IG; Buisson M; Hartgers FC; Burmeister WP; Wiertz EJ; Ressing ME J Immunol; 2011 Feb; 186(3):1694-702. PubMed ID: 21191071 [TBL] [Abstract][Full Text] [Related]
6. Latency pattern of Epstein-Barr virus and methylation status in Epstein-Barr virus-associated hemophagocytic syndrome. Yoshioka M; Kikuta H; Ishiguro N; Endo R; Kobayashi K J Med Virol; 2003 Jul; 70(3):410-9. PubMed ID: 12767005 [TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr virus replicative gene transcription during de novo infection of human thymocytes: simultaneous early expression of BZLF-1 and its repressor RAZ. Kelleher CA; Paterson RK; Dreyfus DH; Streib JE; Xu JW; Takase K; Jones JF; Gelfand EW Virology; 1995 Apr; 208(2):685-95. PubMed ID: 7747440 [TBL] [Abstract][Full Text] [Related]
8. Latent and lytic Epstein-Barr virus replication strategies. Tsurumi T; Fujita M; Kudoh A Rev Med Virol; 2005; 15(1):3-15. PubMed ID: 15386591 [TBL] [Abstract][Full Text] [Related]
9. B-cell polyclonal activation and Epstein-Barr viral abortive lytic cycle are two key features in acute infectious mononucleosis. Al Tabaa Y; Tuaillon E; Jeziorski E; Ouedraogo DE; Bolloré K; Rubbo PA; Foulongne V; Rodière M; Vendrell JP J Clin Virol; 2011 Sep; 52(1):33-7. PubMed ID: 21684200 [TBL] [Abstract][Full Text] [Related]
10. Induction of lytic Epstein-Barr virus (EBV) infection in EBV-associated malignancies using adenovirus vectors in vitro and in vivo. Westphal EM; Mauser A; Swenson J; Davis MG; Talarico CL; Kenney SC Cancer Res; 1999 Apr; 59(7):1485-91. PubMed ID: 10197618 [TBL] [Abstract][Full Text] [Related]
11. Reactivation of Epstein-Barr virus from latency. Amon W; Farrell PJ Rev Med Virol; 2005; 15(3):149-56. PubMed ID: 15546128 [TBL] [Abstract][Full Text] [Related]
12. Induction of Epstein-Barr virus (EBV) reactivation in Raji cells by doxorubicin and cisplatin. Hsu CH; Hergenhahn M; Chuang SE; Yeh PY; Wu TC; Gao M; Cheng AL Anticancer Res; 2002; 22(6C):4065-71. PubMed ID: 12553034 [TBL] [Abstract][Full Text] [Related]
13. Quantitative analysis of Epstein-Barr virus (EBV)-related gene expression in patients with chronic active EBV infection. Iwata S; Wada K; Tobita S; Gotoh K; Ito Y; Demachi-Okamura A; Shimizu N; Nishiyama Y; Kimura H J Gen Virol; 2010 Jan; 91(Pt 1):42-50. PubMed ID: 19793909 [TBL] [Abstract][Full Text] [Related]
14. Detection of Epstein-Barr virus infection and gene expression in human tumors by microarray analysis. Li C; Chen RS; Hung SK; Lee YT; Yen CY; Lai YW; Teng RH; Huang JY; Tang YC; Tung CP; Wei TT; Shieh B; Liu ST J Virol Methods; 2006 May; 133(2):158-66. PubMed ID: 16384612 [TBL] [Abstract][Full Text] [Related]
15. Activation of lytic Epstein-Barr virus (EBV) infection by radiation and sodium butyrate in vitro and in vivo: a potential method for treating EBV-positive malignancies. Westphal EM; Blackstock W; Feng W; Israel B; Kenney SC Cancer Res; 2000 Oct; 60(20):5781-8. PubMed ID: 11059774 [TBL] [Abstract][Full Text] [Related]
16. Human B cells on their route to latent infection--early but transient expression of lytic genes of Epstein-Barr virus. Kalla M; Hammerschmidt W Eur J Cell Biol; 2012 Jan; 91(1):65-9. PubMed ID: 21450364 [TBL] [Abstract][Full Text] [Related]
17. Role of EBERs in the pathogenesis of EBV infection. Iwakiri D; Takada K Adv Cancer Res; 2010; 107():119-36. PubMed ID: 20399962 [TBL] [Abstract][Full Text] [Related]
18. Tumor outgrowth in peripheral blood mononuclear cell-injected SCID mice is not associated with early Epstein-Barr virus reactivation. Piovan E; Bonaldi L; Indraccolo S; Tosello V; Menin C; Comacchio F; Chieco-Bianchi L; Amadori A Leukemia; 2003 Aug; 17(8):1643-9. PubMed ID: 12886254 [TBL] [Abstract][Full Text] [Related]
19. Lytic cycle switches of oncogenic human gammaherpesviruses. Miller G; El-Guindy A; Countryman J; Ye J; Gradoville L Adv Cancer Res; 2007; 97():81-109. PubMed ID: 17419942 [TBL] [Abstract][Full Text] [Related]
20. Functional analysis of the mutated Epstein-Barr virus oncoprotein LMP1(69del): implications for a new role of naturally occurring LMP1 variants. Larcher C; Bernhard D; Schaadt E; Adler B; Ausserlechner MJ; Mitterer M; Huemer HP Haematologica; 2003 Dec; 88(12):1324-35. PubMed ID: 14687985 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]